Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations-Reference-Cited by-同舟云学术

Venous thromboembolism in multiple myeloma - choice of prophylaxis, role of direct oral anticoagulants and special considerations

Published:2018-11 Issue:4 Volume:183 Page:538-556
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Swan Dawn¹^ORCID,Rocci Alberto²³,Bradbury Charlotte⁴⁵,Thachil Jecko²

Affiliation:

1. Department of Haematology; University Hospital Galway; Galway Republic of Ireland

2. Department of Haematology; Manchester University Hospitals NHS Foundation Trust; Manchester United Kingdom

3. Faculty of Biology, Medicine and Health; School of Medical Science; Division of Cancer Science; University of Manchester; Manchester United Kingdom

4. Cellular and Molecular Medicine; University of Bristol; Bristol United Kingdom

5. Bristol Haematology and Oncology Centre; University Hospitals Bristol NHS Foundation Trust; Bristol United Kingdom

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.15684/fullpdf

Reference123 articles.

1. Apixaban for extended treatment of venous thromboembolism;Agnelli;New England Journal of Medicine,2013

2. Thromboprophylaxis in multiple myeloma patients treated with lenalidomide - A systematic review;Al-Ani;Thrombosis Research,2016

3. Causes of death in cancer patients;Ambrus;Journal of Medicine,1975

4. Regulation of fibrinogen biosynthesis: glucocorticoid and interleukin-6 control;Amrani;Blood Coagulation & Fibrinolysis,1990

5. A systematic review on the accumulation of prophylactic dosages of low-molecular-weight heparins (LMWHs) in patients with renal insufficiency;Atiq;European Journal of Clinical Pharmacology,2015

Cited by 52 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Bleeding risk from anticoagulant thromboprophylaxis in patients with multiple myeloma: a MarketScan analysis;Research and Practice in Thrombosis and Haemostasis;2024-05

2. Validation of the IMPEDE VTE score for prediction of venous thromboembolism in Chinese patients with multiple myeloma: A single-center retrospective cohort study;Thrombosis Research;2024-04

3. Antithrombotic utilization, adverse events, and associations with treatment outcomes in multiple myeloma: pooled analysis of three clinical trials;Therapeutic Advances in Medical Oncology;2024-01

4. Hematologists’ awareness of venous thromboembolism in multiple myeloma: a national survey in China;Annals of Medicine;2023-11-20

5. Venous thromboembolism in multiple myeloma: Increasing evidence in support of direct oral anticoagulants;British Journal of Haematology;2023-08-15